ArticleResearch square2021

A Recombinant Protein SARS-CoV-2 Candidate Vaccine Elicits High-titer Neutralizing Antibodies in Macaques.

Gary Baisa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.